ISIL · FOOD & PERSONAL CARE PRODUCTS
ISIL news and notes Ismail Industries Limited
Ismail Industries Limited (ISIL) news and notes: the SuperX note, what changed (3 items) and 1 news story. The note is written by SuperX’s AI from its own figures. What changed is listed newest first. Headlines are the publishers’ own words, linked to them.
What SuperX wrote about ISIL
The price rose 0.29% on 20 Nov. Market flows were negative: foreign investors sold PKR 154.71 million.
The half-year period ends on 31 Dec. Last year the company filed its half-year results on 18 Feb.
Quarterly earnings per share fell 30.4% to 11.17 from 16.05 a year earlier. Sales rose 18.42%.
Written by SuperX’s analyst desk from SuperX’s own figures, from the close of 20 Nov 2026. Each number was checked against those figures. Not advice.
What changed for ISIL, newest first
- 20 Nov 2026Closed 1,790.00, +0.29%. Volume 138, 3.1 times the average of the 30 sessions before it, 45.
- 29 Oct 2026Quarter ended 30 Sep 2026: earnings per share Rs 11.17, sales Rs 29.8 bn, down 30.4% on the same quarter a year before.
- NextHalf-year results (to 31 Dec 2026) expected 12 Feb 2027 – 22 Feb 2027, a projection. An estimate from the dates of the last 8 filings.
As of the close of 20 Nov 2026. Closes and notices: PSX. Volume: against the average of the 30 sessions before the last. Next results: an estimate from the dates of the last 8 filings. Not advice.
News about ISIL
- 16 Oct 2026Ismail Industries Limited · Business Recorder
From 16 Oct 2026 to 16 Oct 2026. A story is listed here when its headline names the company and names three companies or fewer. Headlines are the publishers’ own words and link to them.
More on ISIL
- ISIL share price and overview
- ISIL dividend history
- Food & Personal Care Products sector
- MFL news and notes · Matco Foods Limited
- NESTLE news and notes · Nestle Pakistan Limited
- COLG news and notes · Colgate-Palmolive (Pakistan) Limited
- UPFL news and notes · Unilever Pakistan Foods Limited
Data from PSX via SuperX, delayed and provided for information only — not investment advice. Figures may contain errors; verify with your broker before acting. As of .